Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1358801

Clinical evaluation of droplet digital PCR in the early identification of suspected sepsis patients in the emergency department: A prospective observational study Provisionally Accepted

Sen Jiang1 Dongyang Zhao1 Chunxue Wang1 Xiandong Liu1 Qian Yang1 Xiaowei Bao1 Tiancao Dong1  Li Gen2 Yi Gu1 Yangqin Ye2 Bingke Sun1 Shumin Xu1  Xiaohui Zhou1  Lieying Fan2*  Lunxian Tang1*
  • 1Shanghai East Hospital, School of Medicine, Tongji University, China
  • 2School of Medicine, Tongji University, China

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Background Rapid and accurate diagnosis of the causative agents is essential for clinical management of bloodstream infections (BSIs) that might induce sepsis/septic shock. A considerable number of suspected sepsis patients initially enter the health-care system through an emergency department (ED), hence it is vital to establish an early strategy to recognize sepsis and initiate prompt care in ED. This study aimed to evaluate the diagnostic performance and clinical value of droplet digital PCR (ddPCR) assay in suspected sepsis patients in the ED.Methods This was a prospective single-centered observational study including patients admitted to the ED from 25 October 2022 to 3 June 2023 with suspected BSIs screened by Modified Shapiro Score (MSS) score. The comparison between ddPCR and blood culture (BC) was performed to evaluate the diagnostic performance of ddPCR for BSIs.Meanwhile, correlative analysis between ddPCR and the inflammatory and prognosticrelated biomarkers were conducted to explore the relevance. Further, the health economic evaluation of the ddPCR was analyzed.Results 258 samples from 228 patients, with BC and ddPCR performed simultaneously, were included in this study. We found that ddPCR results were positive in 48.13% (103 of 214) of episodes, with identification of 132 pathogens. In contrast, BC only detected 18 positives, 88.89% of which were identified by ddPCR. When considering cultureproven BSIs, ddPCR shows an overall sensitivity of 88.89% and specificity of 55.61%, the optimal diagnostic power for quantifying BSI through ddPCR is achieved with a copy cutoff of 155.5. We further found that ddPCR exhibited a high accuracy especially in liver abscess patients. Among all the identified virus by ddPCR, EBV has a substantially higher positive rate with a link to immunosuppression. Moreover, the copies of pathogens in ddPCR were positively correlated with various markers of inflammation, coagulation, immunity as well as prognosis. With high sensitivity and specificity, ddPCR facilitates precision antimicrobial stewardship and reduces health care costs.The multiplexed ddPCR delivers precise and quantitative load data on the causal pathogen, offers the ability to monitor the patient's condition and may serve as early warning of sepsis in time-urgent clinical situations as ED.

Keywords: bloodstream infections, Droplet digital PCR, Sepsis, emergency department, clinical validation

Received: 20 Dec 2023; Accepted: 07 May 2024.

Copyright: © 2024 Jiang, Zhao, Wang, Liu, Yang, Bao, Dong, Gen, Gu, Ye, Sun, Xu, Zhou, Fan and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Dr. Lieying Fan, School of Medicine, Tongji University, Shanghai, Shanghai Municipality, China
Dr. Lunxian Tang, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, Shanghai Municipality, China